CASP3 and non-Hodgkin lymphoma: Exposure of the 2 breast carcinoma cell lines tested here to doxorubicin, CDDP, Paclitaxel, Vinblastin or etoposide did not or only weakly increased caspase-3/7 activity while caspase-3/7 activity increased up to 28-fold in NHL cell lines tested after exposure to the same drugs.